ACADIA Pharmaceuticals CEO Stephen Davis' 2020 pay rises 2% to $7.8M
ACADIA Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 30, 2021
ACADIA Pharmaceuticals reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, five executives at ACADIA Pharmaceuticals received on average a compensation package of $3.9M, which is about the same as previous year.
Average pay of disclosed executives at ACADIA Pharmaceuticals
Stephen R. Davis, Chief Executive Officer, received $7.8M in total, which increased by 2% compared to 2019. 42% of Davis' compensation, or $3.3M, was in option awards. Davis also received $439K in non-equity incentive plan, $768K in salary, $3.3M in stock awards, as well as $20K in other compensation.
For fiscal year 2020, the median employee pay was $218,247 at ACADIA Pharmaceuticals. Therefore, the ratio of Stephen R. Davis' pay to the median employee pay was 36 to one.
Srdjan R. Stankovic, President, received a compensation package of $4.9M, which decreased by 5% compared to previous year. 39% of the compensation package, or $1.9M, was in option awards.
Michael J. Yang, Former Executive Vice President, Chief Commercial Officer, earned $2.6M in 2020, a 11% decrease compared to previous year.
Elena H. Ridloff, Chief Financial Officer, received $2.5M in 2020, which increases by 26% compared to 2019.
Austin D. Kim, General Counsel, earned $1.7M in 2020, a 8% decrease compared to previous year.
Related executives
Stephen Davis
ACADIA Pharmaceuticals
Chief Executive Officer
Srdjan Stankovic
ACADIA Pharmaceuticals
President
Austin Kim
ACADIA Pharmaceuticals
General Counsel
Elena Ridloff
ACADIA Pharmaceuticals
Chief Financial Officer
Michael Yang
ACADIA Pharmaceuticals
Former Executive Vice President, Chief Commercial Officer
You may also like
Source: SEC filing on April 30, 2021.